Black Diamond Therapeutics, Inc. (BDTX:NASDAQ) closed at $1.88 on October 23, 2026, down 9.62% on the day. The stock trades 61.9% below its 52-week high of $4.94 and 17.5% above its 52-week low of $1.60. Over the past year, it lost 52.2%. Black Diamond Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, BDTX closed higher on 115 days (46%). Its best day was May 20, 2026 (+20.00%) and its worst was May 22, 2026 (-35.77%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 1 time.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform namely, Mutation-Allostery-Pharmacology which is targeting mutations in cancer.
Find more stocks like BDTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.